SinFlogo®

SinFlogo® by GP Pharma consists of components that have been shown to significantly alleviate the symptoms associated with an inflammatory state, and pain. Find reasonable use in all chronic inflammations where prolonged treatments without side effects are needed.

INGREDIENTS

Each tablet contains:

Bromelain; Curcumin e.s. (curcuma longa L. - rhizoma); Boswellia e.s. (Boswellia serrata Roxb. - gummi).

THERAPEUTIC PROPERTIES

Bromelain 500 mg is a proteolytic enzyme; indicated in all cases of inflammation and/or edema of soft tissues. Bromelain is very effective in dyspepsia due to the deficiency of gastric and pancreatic enzymes. It can be useful in both rheumatoid arthritis and osteoarthritis. It is also able to promote the drainage of fluid accumulated in the tissues that cause a feeling of heaviness and swelling of the lower extremities.

Curcumin 100 mg has antioxidant, anti-inflammatory and preventive

chemo properties. The association with bromelain increases the bioavailability and synergizes with anti-inflammatory activity.

Boswellia 100 mg is indicated in chronic inflammatory diseases with immunological or allergic pathogenesis: acute upper respiratory tract infections, inflammatory colitis, rheumatoid arthritis, dermatitis, periarthritis, rheumatic problems and Crohn's disease.

DOSAGE

2 tablets per day, morning and evening, away from meals for a period of not less than 10 days. One symptom tablet for 20 days is recommended as maintenance therapy to improve symptoms.

WARNINGS

Do not exceed the recommended daily dose. Keep out of the reach of children. Dietary Supplements are not a substitute for a varied and balanced diet and a healthy lifestyle. Do not take during pregnancy and lactation. It is contraindicated in patients receiving oral anticoagulation

PERIOD OF VALIDITY

36 months in a closed package and properly stored

STORAGE PRECAUTIONS

Store at temperatures below 25 °C, away from direct sources of heat and moisture, keep away from the sunlight. Do not disperse in the environment after use.

pdf

Comments are closed.